Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Clarcor: Filtering Our Filth
- Clarcor makes mobile, industrial, and environmental filtration systems to help companies clear the air in our dirty world. The pressure to be germ-free and green means Clarcor is cleaning up on the stock market.
- Videos 2008-03-31
- Coating Polymers for Colon Specific Drug Delivery: A Comparative in Vitro Evaluation
- Colon is being extensively investigated as a drug delivery site. This paper is basically a comparison of the usual enteric coating polymers viz. Eudragit, a cellulose acetate phathalate with shellac and ethyl cellulose, as carriers for colon specific drug delivery. Lactose based indomethacin tablets were prepared. These were coated with...
- White papers 2004-08-12
Additional Resources
- Everybody Loves Sanofi's Giant Human Colon
- Sanofi-Aventis has installed a 20-foot long, walk-through model of a human colon in NYC's Times Square see video. The stunt is to promote colon exams for the middle aged and Sanofi's Eloxatin, for which the FDA added a colon cancer approval in February. The...
- Blog posts 2009-03-05
- Intra-Patient Prone to Supine Colon Registration for Synchronized Virtual Colonoscopy
- This paper presents an automated method for colon registration. The method uses dynamic programming to align data defined on colon center-line paths, as extracted from the prone and supine scans. This data may include information such as path length and curvature as well as descriptors of the shape and size...
- White papers 2002-11-13
- Israel scientists make colon cancer cell breakthrough
- JERUSALEM AFP ? Researchers at Israel's Weizmann Institute said Tuesday they have managed for the first time to halt the spread of colon cancer cells in laboratory tests. Scientists at the center near Tel Aviv believe that their breakthrough could help pharmaccologists develop drugs to prevent or reverse colon...
- Research articles 2004-01-06
- Colon, Schilling win debuts with teams
- Bartolo Colon's debut with the Anaheim Angels on Tuesday was a memorable one, and the same was true for Boston Red Sox right-hander Curt Schilling. Colon, who was part of the $146 million worth of offseason additions, pitched six innings in the Angels' 10-5 win against the Seattle Mariners...
- Research articles 2004-04-07
- Sigmoidoscopy fails to detect polyps in colon of two-thirds women
- WASHINGTON AFP — Sigmoidoscopy, a technique commonly used to check for colon cancer, fails to show precancerous polyps in two-thirds of women tested, according to a study. Earlier research had already showed a failure rate in men of 30 percent using the technique, which examines the lowest one-fourth of...
- Research articles 2005-05-18
- Angels' hurler Colon on disabled list
- MINNEAPOLIS, United States AFP — The Angels placed Cy Young Award winner Bartolo Colon on the 15-day disabled list with right shoulder inflammation. Colon, who won 21 games and posted a 3.46 ERA in 2005, has had a rough start to 2006, going 0-2 with 7.07 ERA in three...
- Research articles 2006-04-20
- GENZYME GENETICS: Genzyme Genetics offers two new tests to detect hereditary risk of colon cancer.
- M2 PRESSWIRE-1 July 1999-GENZYME GENETICS: Genzyme Genetics offers two new tests to detect hereditary risk of colon cancer C1994-99 M2 COMMUNICATIONS LTD RDATE:010799 Genzyme Genetics announced today that it is introducing two new genetic tests designed to detect inherited gene mutations...
- Research articles 1999-07-01
- MDS Provides New Genetic Test for Colon and Uterine Cancer, Canadians with family history of colon cancer now being analyzed with Myriad's COLARIS(TM) genetic test.
- TORONTO, Dec 06, 2000 MDS Inc. (NYSE:MDZ, TSE:MDS) announced today that COLARISTM, Myriad Genetics, Inc.'s new genetic predictive test for colon and uterine cancer is now available across Canada through the MDS national network. The COLARIS test detects disease-causing mutations in two genes,...
- Research articles 2000-12-06
- Massey Knakal Realty Services: Marisol Colon
- Massey Knakal Realty Services announced that Marisol Colon has joined the firm as an executive assistant to chief operating officer Tim King in the firm's Brooklyn office. Prior to joining Massey Knakal, Colon served as an administrative assistant with the specialty services department of Edelman Public Relations. Colon...
- Research articles 2005-06-08
- Baseball: Bartolo Colon grabs AL Player of the Week honors.
- New York, NY, Sep 15, 2003 The Sports Network via COMTEX Chicago White Sox starting pitcher Bartolo Colon has been named American League Player of the Week for the period of September 8-14. The hard-throwing righthander was 2-0 with a 1.00...
- Research articles 2003-09-15
- What I Need to Know About Colon Polyps
- This paper discusses and provides information on Colon Polyps. A polyp is extra tissue that grows inside the body. Most polyps are not harmful. Symptoms may include constipation or diarrhea for more than a week or blood on your underwear, on toilet paper, or in your stool. Many polyps do...
- White papers 2003-04-01
- Role of the P53/P21 System in the Response of Human Colon Carcinoma Cells to Doxorubicin
- Colon adenocarcinomas are refractory to a number of widely used anticancerm agents. Multifactorial mechanisms have been implicated in this intrinsically resistant phenotype, including deregulation of cell death pathways. In this regard, the p53 protein has a well established role in the control of tumor cell response to DNA damaging agents;...
- White papers 2004-12-15
- Big grant will back cancer research.(National Cancer Institute grant to Case Western Reserve University and Universtiy Hospitals of Cleveland for colon cancer research)(Brief Article)
- Researchers at Case Western Reserve University and University Hospitals of Cleveland have received a $6.7 million grant from the National Cancer Institute to identify the genes that cause colon cancer to spread. Using "gene chip" technol Researchers at Case Western Reserve University and...
- Research articles 2000-10-09
- Chicago Observer: His not-so-fun stay at the YMCA is now a matter of ward politics.(Briefs)(Rey Colon)
- Byline: Steven R. Strahler YMCA executive Rey Colon, forced to quit his job last summer when he was gearing up for a City Council race, says he warned his employer, ``You guys just fired an alderman.'' The prediction-or perhaps nightmare, from the Byline:...
- Research articles 2003-03-03
- HNBA Supports Nomination of Magistrate Judge Aida M. Delgado-Colon to U.S. District Court for the District of Puerto Rico
- WASHINGTON, Feb. 6 /U.S. Newswire/ -- The Hispanic National Bar Association HNBA endorses the confirmation of United States Magistrate Judge Aida M. Delgado-Colon to a seat on the United States District Court for the District of Puerto Rico. The HNBA uWASHINGTON, Feb. 6 /U.S. Newswire/ -- The Hispanic National...
- Research articles 2006-02-06
- Weddings with the Wi-Fi guy: veteran digital shooter Mike Colon taps into Nikon's breakthrough imaging technology to facilitate his workflow.(Nikon D2H)
- Mike Colon was an early adopter of digital imaging, fully embracing the medium four years ago, and has remained a staunch fan of nearly all of Nikon's professional photography innovations since. "I started using the D2H in early 2004," he Mike Colon was an...
- Research articles 2005-03-01
- Senators Urged to Fight Colon Cancer; American Cancer Society Takes to the Airwaves; Ads Run Across the Country
- WASHINGTON, July 8 /U.S. Newswire/ -- Just one week after President Bush underwent a colonoscopy to check for early signs of colon cancer, the American Cancer Society, the nation's leading voluntary health agency, is sending a strong message of thanks to WASHINGTON, July 8 /U.S. Newswire/ -- Just one week...
- Research articles 2002-07-08
- Intracel and FDA Agree on Pivotal Phase III Clinical Protocol for Colon Cancer Vaccine; OncoVAX® Vaccine Designed to Prevent Tumor Recurrence in Stage II Colon Cancer Patients Following Surgical Tumor Removal
- FREDERICK, Md. -- Intracel, a biopharmaceutical company developing and commercializing cancer vaccines and other immunotherapeutic products, announced today that it has reached agreement with the U.S. Food and Drug Administration FDA on a pivotal Phase III clinical protocol for its OncoVAXR vaccine, a patient-specific tumor cell vaccine that is intended...
- Research articles 2006-04-27
- << Previous
- page 1 of 1
- Next >>
